Close Menu

The DrugMonkey blogger, who apparently works for NIH or another US government agency, says that the method for deciding on the order in which authors are listed on papers needs to be revised. PIs are always last, leaving everyone who did the heavy lifting vying for the coveted first-author position, according to the post. DrugMonkey's proposal: let reviewers flag which parts of the paper are most important, and then assign authorship order based on who contributed to those key parts.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.